6,034 filings
Page 5 of 100
6-K
GSK
GSK Plc
9 Jan 24
GSK Enters Agreement to Acquire Aiolos Bio
6:16am
6-K
GSK
GSK Plc
2 Jan 24
Total Voting Rights
10:35am
6-K
GSK
GSK Plc
21 Dec 23
Director/pdmr Shareholding
10:39am
6-K
GSK
GSK Plc
18 Dec 23
Jemperli Plus Zejula Trial Meets Endpoint
6:34am
6-K
GSK
GSK Plc
13 Dec 23
Director/pdmr Shareholding
11:02am
6-K
GSK
GSK Plc
12 Dec 23
Japan Accepts Arexvy Filing for at Risk Adults
6:06am
6-K
GSK
GSK Plc
11 Dec 23
Jemperli Plus Chemotherapy Eu Authorisation
6:20am
6-K
GSK
GSK Plc
4 Dec 23
GSK Publishes Provisional 2024 Dividend Dates
12:21pm
6-K
GSK
GSK Plc
1 Dec 23
Total Voting Rights
11:31am
6-K
GSK
GSK Plc
30 Nov 23
Block Listing Application
8:08am
6-K
GSK
GSK Plc
29 Nov 23
Holding(s) In Company
12:24pm
6-K
GSK
GSK Plc
27 Nov 23
GSK Announces Positive DREAMM-7 Headline Results
9:14am
6-K
GSK
GSK Plc
21 Nov 23
Director/pdmr Shareholding
11:09am
6-K
GSK
GSK Plc
15 Nov 23
Block Listing Interim Review
11:53am
6-K
GSK
GSK Plc
13 Nov 23
Director/pdmr Shareholding
12:08pm
6-K
GSK
GSK Plc
13 Nov 23
GSK Receives Positive CHMP Opinion for Momelotinib
9:04am
6-K
GSK
GSK Plc
1 Nov 23
Total Voting Rights
1:01pm
6-K
GSK
GSK Plc
1 Nov 23
3RD Quarter Results
12:51pm
6-K
GSK
GSK Plc
30 Oct 23
Jemperli Trial Meets Overall Survival Endpoint
7:10am
6-K
GSK
GSK Plc
26 Oct 23
Nmpa Approves Vocabria+rekambys In China
8:17am